HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

ethoxyresorufin

structure
Also Known As:
7-ethoxy-3H-phenoxazin-3-one; 7-ethoxyresorufin; 7-ethoxyphenoxazone
Networked: 31 relevant articles (1 outcomes, 4 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Guseva, G V: 2 articles (01/2014 - 01/2014)
2. Aksenov, I V: 2 articles (01/2014 - 01/2014)
3. Kravchenko, L V: 2 articles (01/2014 - 01/2014)
4. Trusov, N V: 2 articles (01/2014 - 01/2014)
5. Beketova, N A: 1 article (01/2014)
6. Tutel'yan, V A: 1 article (01/2014)
7. Avrent'eva, L I: 1 article (01/2014)
8. Ahlstrøm, Oystein: 1 article (08/2013)
9. Muir, Derek: 1 article (08/2013)
10. Jørgensen, Even H: 1 article (08/2013)

Related Diseases

1. Infection
2. Malaria
3. Body Weight (Weight, Body)
11/01/2002 - "The study confirmed previous findings that induction of hepatic ethoxyresorufin deethylase (EROD) activity takes place at daily intake levels 0.15 ng fish-derived CDD/F-TEQs/kg body weight. "
10/01/2006 - "Lesser scaup treated with BNF at 20 or 100 mg/kg body weight showed approximately 6- to 18-fold increases in four monooxygenases (benzyloxyresorufin-O-dealkylase, ethoxyresorufin-O-dealkylase, methoxyresorufin-O-dealkylase, and pentoxyresorufin-O-dealkylase). "
06/20/2003 - "In animals fed DHEA at 200 or 400 mg/kg body weight every other day for 2 weeks prior to exposure to the aryl hydrocarbon dimethylbenz[a]anthracene (DMBA, 5 mg/kg), there was a dose-dependent decrease in hepatic CYP activity, as measured by ethoxyresorufin-O (EROD) assay, from 37.1 to 22.9 and 14.7 pmoles/min/10 microg microsomes, respectively. "
01/01/2014 - "Supplementation of the ration with eicosapentaenoic and docosahexaenoic ω-3 polyunsaturated fatty acids (PUFA) in doses of 0.3 and 1 g/kg body weight for 4 weeks had no effect on ethoxyresorufin O-dealkylase (EROD) activity and expression of the CYP1A1 gene in male Wistar rats, but caused a dose-dependent increase in methoxyresorufin O-dealkylase (MROD) activity of CYP1A2 (by 28 and 73%, respectively) without significant changes in CYP1A2 mRNA expression. "
01/01/2005 - "quinquefolius extracts did not affect body weight gain, absolute or relative liver weight, hepatic CYP2B1, CYP3A23, or CYP1A2 mRNA expression, or microsomal CYP2B-mediated 7-benzyloxyresorufin O-dealkylation (BROD) or CYP1A-mediated 7-ethoxyresorufin O-dealkylation (EROD) activity. "
4. Medulloblastoma
5. Squamous Cell Carcinoma (Epidermoid Carcinoma)

Related Drugs and Biologics

1. Cytochrome P-450 CYP1A1 (CYP1A1)
2. Cytochrome P-450 Enzyme System (Cytochrome P450)
3. Clotrimazole (Lotrimin)
4. Benzo(a)pyrene
5. Flavones
6. Cimetidine (Biomet)
7. resveratrol
8. Cytochromes
9. Cytochrome P-450 CYP2B1 (PROD)
10. Cytochrome P-450 CYP1A2 (CYP1A2)